Literature DB >> 18082181

Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains.

Martin Stöckl1, Patricia Fischer, Erich Wanker, Andreas Herrmann.   

Abstract

Previous studies indicate that binding of alpha-synuclein to membranes is critical for its physiological function and the development of Parkinson's disease (PD). Here, we have investigated the association of fluorescence-labeled alpha-synuclein variants with different types of giant unilamellar vesicles using confocal microscopy. We found that alpha-synuclein binds with high affinity to anionic phospholipids, when they are embedded in a liquid-disordered as opposed to a liquid-ordered environment. This indicates that not only electrostatic forces but also lipid packing and hydrophobic interactions are critical for the association of alpha-synuclein with membranes in vitro. When compared to wild-type alpha-synuclein, the disease-causing alpha-synuclein variant A30P bound less efficiently to anionic phospholipids, while the variant E46K showed enhanced binding. This suggests that the natural association of alpha-synuclein with membranes is altered in the inherited forms of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18082181     DOI: 10.1016/j.jmb.2007.11.051

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  64 in total

1.  Effects of curvature and composition on α-synuclein binding to lipid vesicles.

Authors:  Elizabeth R Middleton; Elizabeth Rhoades
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

2.  Membrane lipid modification by docosahexaenoic acid (DHA) promotes the formation of α-synuclein inclusion bodies immunopositive for SUMO-1 in oligodendroglial cells after oxidative stress.

Authors:  Michael Riedel; Olaf Goldbaum; Michael Wille; Christiane Richter-Landsberg
Journal:  J Mol Neurosci       Date:  2010-08-20       Impact factor: 3.444

Review 3.  Molecular interactions of amyloid nanofibrils with biological aggregation modifiers: implications for cytotoxicity mechanisms and biomaterial design.

Authors:  Durga Dharmadana; Nicholas P Reynolds; Charlotte E Conn; Céline Valéry
Journal:  Interface Focus       Date:  2017-06-16       Impact factor: 3.906

4.  Aggregation of α-synuclein in S. cerevisiae is associated with defects in endosomal trafficking and phospholipid biosynthesis.

Authors:  James H Soper; Victoria Kehm; Christopher G Burd; Vytas A Bankaitis; Virginia M-Y Lee
Journal:  J Mol Neurosci       Date:  2010-10-02       Impact factor: 3.444

5.  Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy.

Authors:  Christina R Bodner; Christopher M Dobson; Ad Bax
Journal:  J Mol Biol       Date:  2009-05-27       Impact factor: 5.469

6.  Stability of protein-decorated mixed lipid membranes: The interplay of lipid-lipid, lipid-protein, and protein-protein interactions.

Authors:  Stephan Loew; Anne Hinderliter; Sylvio May
Journal:  J Chem Phys       Date:  2009-01-28       Impact factor: 3.488

7.  Pinched multilamellar structure of aggregates of lysozyme and phosphatidylserine-containing membranes revealed by FRET.

Authors:  Ana Coutinho; Luís M S Loura; Alexandre Fedorov; Manuel Prieto
Journal:  Biophys J       Date:  2008-07-25       Impact factor: 4.033

8.  Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated α-synuclein.

Authors:  Emma I O'Leary; Zhiping Jiang; Marie-Paule Strub; Jennifer C Lee
Journal:  J Biol Chem       Date:  2018-05-31       Impact factor: 5.157

Review 9.  Biophysics of α-synuclein membrane interactions.

Authors:  Candace M Pfefferkorn; Zhiping Jiang; Jennifer C Lee
Journal:  Biochim Biophys Acta       Date:  2011-07-28

10.  Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy.

Authors:  Christina R Bodner; Alexander S Maltsev; Christopher M Dobson; Ad Bax
Journal:  Biochemistry       Date:  2010-02-09       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.